GHDX - Genomic Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
33.61
+0.05 (+0.15%)
As of 12:18PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close33.56
Open33.37
Bid33.60 x 600
Ask33.63 x 100
Day's Range33.06 - 33.73
52 Week Range26.37 - 33.97
Volume73,320
Avg. Volume110,109
Market Cap1.16B
Beta0.47
PE Ratio (TTM)-224.07
EPS (TTM)-0.15
Earnings DateOct 30, 2017 - Nov 3, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est32.60
Trade prices are not sourced from all markets
  • Genomic Health's Cost Pressure Mounts, Cancer Tests Strong
    Zacks14 days ago

    Genomic Health's Cost Pressure Mounts, Cancer Tests Strong

    Concerns related to Genomic Health's (GHDX) strong dependence on breast cancer tests still linger. Also, higher production cost and expenses continue to weigh heavily on the company's margins.

  • We're sorry this is all we were able to find about this topic.